Design, synthesis and molecular modeling study of substituted indoline-2-ones and spiro[indole-heterocycles] with potential activity against Gram-positive bacteria

被引:7
作者
Radwan, Awwad Abdoh [1 ,2 ]
Aanazi, Fares Kaed [1 ,3 ]
Al-Agamy, Mohammed [3 ,4 ]
Mahrous, Gamal Mohammad [3 ]
机构
[1] King Saud Univ, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
[2] Assiut Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Assiut 71527, Egypt
[3] King Saud Univ, Coll Pharm, Dept Pharmaceut, Riyadh, Saudi Arabia
[4] Al Azhar Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt
关键词
2-indolinone; spiro[indole-heterocyles; anti-microbial; docking study; IN-SILICO; ANTIMICROBIAL ACTIVITY; BIOLOGICAL EVALUATION; DERIVATIVES; ANTIMYCOBACTERIAL; INHIBITORS; SCHIFF; BASES; VITRO;
D O I
10.2478/acph-2022-0004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Longstanding and firsthand infectious diseases are challenging community health threats. A new series of isatin derivatives bearing beta-hydroxy ketone, chalcone, or spiroheterocycle moiety, was synthesized in a good yield. Chemical structures of the synthesized compounds were elucidated using spectroscopic techniques and elemental analysis. Antibacterial activities of the compounds were then evaluated in vitro and by in silico modeling. The compounds were more active against Gram-positive bacteria, Staphylococcus aureus (MIC = 0.026-0.226 mmol L-1) and Bacillus subtilis (MIC = 0.348-1.723 mmol L-1) than against Gram-negative bacteria (MIC = 0.817-7.393 mmol L-1). Only 3-hydroxy-3-(2-(2,5-dimethylthiophen-3-yl)-2-oxoethyl)indolin-2-one (1b) was found as active as imipenem against S. aureus (MIC = 0.026 mmol L-1). In silico docking of the compounds in the binding sites of a homology modeled structure of S. aureus histidine kinase-Walk allowed us to shed light on the binding mode of these novel inhibitors. The highest antibacterial activity of 1b is consistent with its highest docking score values against S. aureus histidine kinase.
引用
收藏
页码:79 / 95
页数:17
相关论文
共 44 条
[1]   Synthesis and evaluation of some new spiro indoline-based heterocycles as potentially active antimicrobial agents [J].
Abdel-Rahman, AH ;
Keshk, EM ;
Hanna, MA ;
El-Bady, SM .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (09) :2483-2488
[2]   Schiff bases of indoline-2,3-dione (isatin) with potential antiproliferative activity [J].
Aboul-Fadl, Tarek ;
Radwan, Awwad A. ;
Attia, Mohamed I. ;
Al-Dhfyan, Abdullah ;
Abdel-Aziz, Hatem A. .
CHEMISTRY CENTRAL JOURNAL, 2012, 6
[3]  
Aboul-Fadl T, 2012, DIG J NANOMATER BIOS, V7, P329
[4]  
Adam A. K., 2017, MOLECULES, V22, DOI [10.3390/molecules22122221, DOI 10.3390/MOLECULES22122221]
[5]   Synthesis and characterisations of copper(II) complexes of 5-methoxyisatin thiosemicarbazones: Effect of N-terminal substitution on DNA/protein binding and biological activities [J].
Aneesrahman, K. N. ;
Ramaiah, K. ;
Rohini, G. ;
Stefy, G. P. ;
Bhuvanesh, N. S. P. ;
Sreekanth, A. .
INORGANICA CHIMICA ACTA, 2019, 492 (131-141) :131-141
[6]   Bacterial Histidine Kinases as Novel Antibacterial Drug Targets [J].
Bem, Agnieszka E. ;
Velikova, Nadya ;
Teresa Pellicer, M. ;
van Baarlen, Peter ;
Marina, Alberto ;
Wells, Jerry M. .
ACS CHEMICAL BIOLOGY, 2015, 10 (01) :213-224
[7]   Conformational dynamics of the essential sensor histidine kinase WalK [J].
Cai, Yongfei ;
Su, Mingyang ;
Ahmad, Ashfaq ;
Hu, Xiaojie ;
Sang, Jiayan ;
Kong, Lingyuan ;
Chen, Xingqiang ;
Wang, Chen ;
Shuai, Jianwei ;
Han, Aidong .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2017, 73 :793-803
[8]   BLAST plus : architecture and applications [J].
Camacho, Christiam ;
Coulouris, George ;
Avagyan, Vahram ;
Ma, Ning ;
Papadopoulos, Jason ;
Bealer, Kevin ;
Madden, Thomas L. .
BMC BIOINFORMATICS, 2009, 10
[9]   SYNTHESIS AND MICROBIOLOGICAL PROPERTIES OF 3-AMINO-1-HYDROXY-2-INDOLINONE AND RELATED COMPOUNDS [J].
DAVIS, AL ;
SMITH, DR ;
MCCORD, TJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (09) :1043-1045
[10]   Synthesis and antimicrobial activity of some new 2-indolinone derived oximes and spiro-isoxazolines [J].
El-Gendy, AA ;
Ahmedy, AM .
ARCHIVES OF PHARMACAL RESEARCH, 2000, 23 (04) :310-314